Clinical Trials Directory

Trials / Sponsors / Caliway Biopharmaceuticals Co., Ltd.

Caliway Biopharmaceuticals Co., Ltd.

Industry · 13 registered clinical trials — 2 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingA Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing Subcutaneous Fat ( SUPREME-02 )
Subcutaneous Fat
Phase 32026-10-01
Not Yet RecruitingA Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing Subcutaneous Fat
Subcutaneous Fat
Phase 32026-07-01
Active Not RecruitingA Study to Evaluate the Efficacy and Safety of CBL-514 Compared to Placebo in Participants With Dercum's Disea
Dercum's Disease
Phase 22024-11-27
CompletedA Phase 2b Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing Subcutaneous Fat.
Subcutaneous Fat
Phase 22023-11-10
CompletedA Study to Evaluate the Efficacy, Safety and Tolerability of CBL-514 Injection for Reducing Abdominal Subcutan
Subcutaneous Fat
Phase 22023-05-30
CompletedA Study to Evaluate the Efficacy and Safety of CBL-514 in Participants With EFP; Cellulite (Stage 2)
Cellulite
Phase 22023-05-10
CompletedA Study to Evaluate the Efficacy and Safety of CBL-514 in Participants With EFP; Cellulite (Stage 1)
Cellulite
Phase 22023-01-09
CompletedA Study to Evaluate the Efficacy and Safety of CBL-514 in Participants With Dercum's Disease Lipomas
Dercum's Disease
Phase 22022-10-03
CompletedA Study to Evaluate the Efficacy, Safety, and Tolerability of CBL-514 Injection for Reducing Subcutaneous Fat
Subcutaneous Fat
Phase 22022-02-14
CompletedA Study to Evaluate the Pharmacokinetic Profile of CBL-514 Injection in Healthy Volunteers
Subcutaneous Fat
Phase 22022-02-11
CompletedA Study to Evaluate the Efficacy, Safety and Tolerability of CBL-514 Injection for Reducing Subcutaneous Fat (
Subcutaneous Fat
Phase 22020-12-09
CompletedA Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of CBL-514 Injection for Reducing Conve
Subcutaneous Fat
Phase 22020-02-03
CompletedA Phase 1 Study to Evaluate the Safety and Tolerability of CBL-514 Injection on Convexity or Fullness of Abdom
Subcutaneous Fat
Phase 12018-11-27